Primary cells are derived directly from living tissue and therefore more closely replicate the physiology of biological systems. They are increasingly useful in life science research, ADME/toxicity studies and pharmaceutical development, and in diverse applications where cell lines do not replicate the target biological system. We offer primary cells from PromoCell (available in select geographies) and from Cell Applications, Inc. (CAI).
Our manufacturers have refined the isolation, purification, subculture, and growth of over 100 primary cell types. Cells come with the promise of purity, low passage, rigorous characterization, and strict quality control. Harmonized media and reagents provide optimal performance, ensuring confidence in the utility of these cells and their supporting products in your application.
PromoCell® products are available in North America, Canada, and select countries in Europe
Primary human cells may provide biomedical researchers with more meaningful models of human health and disease, as their physiology more closely replicates that of the biological tissues from which they are extracted. Primary cells are especially relevant for applications where immortalized cell lines have attributes that can confound results.
Our primary cell inventory includes cells and precisely-formulated media from industry-leading manufacturer PromoCell. This collection offers the broadest range of validated, ethically-sourced human primary and stem cells, plus human blood cells—along with culture media optimized for expert culture of these phenotypes.
Unique formulations for groundbreaking cancer studies include a xeno-free (XF) medium for cultivating cancer lines in 3D. The Primary Cancer Culture System is a complete solution for the selective culture of malignant cells extracted from primary tumors or patient xenografts. Renowned technical support for PromoCell® products starts here, with detailed protocols and application documents for successful use of these exceptional cells and reagents.
In partnership with BioIVT, we offer a comprehensive portfolio of fully characterized, ready-to-use normal and disease state PBMCs as well as a variety of immune cell subsets.
Pre-isolated immune cells support faster results with less time spent on sample preparation, enabling you to concentrate on your assays. From basic research to drug discovery, biotherapeutic development, and translational studies, we provide reliable access to immune cells.